← Leaderboards
Bryon Duane Johnson
Medical College Of Wisconsin
$4,264,710
Attributed
$4,264,710
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $543K · FY2005–13$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$4,264,710 · 3
By mechanism
R01$4,152,213 · 2
R29$112,497 · 1
Top collaborators
No co-investigators on record.
Most similar at Medical College Of Wisconsin
Same institution · by research overlap
- Fritz Sieber$1,073,286
- David Allen Wilcox$6,145,617
- William R. Drobyski$18,734,918
- David A Margolis$268,920
- Marcelo C. Pasquini$17,137,619
Others in their field
Top investigators on “Laboratory Mouse”
- Richard K. Wilson · Washington University$122,948,010
- Frank Patrick McCormick · University Of California San Francisco$87,382,096
- David Heimbrook · Leidos Biomedical Research, Inc.$81,904,667
- Kc Kent Lloyd · University Of California At Davis$56,148,943
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,869,943
- Carol J Bult · Jackson Laboratory$47,860,052
Research focus
Laboratory MouseBone Marrow TransplantationNeuroblastomaSolid NeoplasmIn VivoPre-ClinicalNeoplastic CellHelper T LymphocyteCellsMalignant NeoplasmsChildAutologousImmunotherapyInstitutionImmunityChemotherapyDisease-Free SurvivalGraft Versus Host DiseaseCd4 Positive T LymphocytesMalignant Childhood NeoplasmImmune SystemImmuneCd8b1 GeneStaging
Grant awards (16)
Optimizing Immunotherapy for Neuroblastoma after BMT$277,478
R01 · FY2013 · CA · contact PI
Optimizing Immunotherapy for Neuroblastoma after BMT$295,189
R01 · FY2012 · CA · contact PI
Optimizing Immunotherapy for Neuroblastoma after BMT$295,189
R01 · FY2011 · CA · contact PI
Optimizing Immunotherapy for Neuroblastoma after BMT$304,318
R01 · FY2010 · CA · contact PI
Optimizing Immunotherapy for Neuroblastoma after BMT$304,318
R01 · FY2009 · CA · contact PI
Optimizing Immunotherapy for Neuroblastoma after BMT$291,566
R01 · FY2008 · CA · contact PI
Optimizing Immunotherapy for Neuroblastoma after BMT$291,566
R01 · FY2007 · CA · contact PI
Optimizing Immunotherapy for Neuroblastoma after BMT$300,274
R01 · FY2006 · CA · contact PI
Optimizing Immunotherapy for Neuroblastoma after BMT$307,500
R01 · FY2005 · CA
CD4 Regulator T Cells Suppress Alloreactivity after BMT$235,463
R01 · FY2005 · CA
Optimizing Immunotherapy for Neuroblastoma after BMT$307,500
R01 · FY2004 · CA
CD4 Regulator T Cells Suppress Alloreactivity after BMT$235,463
R01 · FY2004 · CA
CD4 Regulator T Cells Suppress Alloreactivity after BMT$235,463
R01 · FY2003 · CA
CD4 Regulator T Cells Suppress Alloreactivity after BMT$235,463
R01 · FY2002 · CA
CD4 Regulator T Cells Suppress Alloreactivity after BMT$235,463
R01 · FY2001 · CA
DLI THERAPY AND BMT--EFFECTOR AND REGULATORY MECHANISMS$112,497
R29 · FY2000 · CA